Long-Term Follow-Up of Zidovudine Therapy in Asymptomatic HIV Infection: Results of Multicenter Cohort Study
Description:
Research published in the Journal of Acquired Immune Deficiency Syndromes that explained that zidovudine (AZT) is only beneficial to people with HIV/AIDS within the first year of treatment and that after three years there were no sustained clinical benefit.
Date:
1994
Creator:
Journal of Acquired Immune Deficiency Syndromes
Item Type:
Refine your search to only
Text
Partner:
UNT Libraries Special Collections